Visco Vision Inc. AI Stock Analysis
Visco Vision Inc. (6782) AI Stock Analysis
Visco Vision Inc.
(TWSE:6782)
Visco Vision scores well on the strength of rapid revenue growth, expanding margins and a ~26% return on equity, backed by a well-capitalised balance sheet. Technicals reinforce the case, with the shares trading above all key moving averages and positive MACD momentum. Valuation is attractive at a 14.5x P/E with a 3.06% dividend yield and low beta. The principal risks holding the score back are negative free cash flow and weaker cash conversion during a capital-intensive expansion phase, rising debt to fund that build-out, and decelerating revenue growth in a business that has shown sensitivity to demand cycles.
Visco Vision Inc. (6782) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 17.64B
- Dividend Yield
- 2.97%
- Average Volume (3M)
- 526.42K
- Price to Earnings (P/E)
- 15.1
- Beta (1Y)
- 0.42
- Revenue Growth
- 23.29%
- EPS Growth
- 55.47%
- Country
- TW
- Employees
- 16,368
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Instruments & Supplies
Visco Vision Inc. Business Overview & Revenue Model
Company Description
Visco Vision, Inc. engages in the production and sale of disposable soft contact lenses, It specializes in design and production of disposable contact lenses with different water content and oxygen permeability According to the same use cycle, it can...
Visco Vision Inc. Financial Statement Overview
Summary
Strong earnings profile anchors the score: revenue has more than doubled since 2021 to NT$5.02bn TTM, with gross margin widening to ~46.6%, operating margin to ~28.7% and net income nearly quadrupling since 2023 (Income Statement 87). The balance sheet is solid (Balance Sheet 80) with equity funding ~59% of assets, ROE near 26% and leverage far below 2021 levels, though debt recently rose to NT$1.84bn (0.38x debt/equity) to fund capacity expansion. Cash flow is the weak link (Cash Flow 63): operating cash flow of ~NT$1.58bn is healthy, but heavy capex has pushed free cash flow to negative NT$406m and cash conversion below 1x net income. Slowing revenue growth to single digits and demonstrated demand cyclicality temper an otherwise attractive profile.
Income Statement
87Very PositiveBalance Sheet
80PositiveCash Flow
63Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.02B | 4.22B | 3.67B | 2.40B | 2.78B | 1.96B |
| Gross Profit | 2.34B | 1.91B | 1.43B | 857.16M | 1.23B | 839.34M |
| EBITDA | 2.04B | 1.67B | 1.21B | 733.59M | 1.08B | 667.51M |
| Net Income | 1.18B | 886.61M | 636.47M | 301.61M | 617.43M | 443.63M |
Balance Sheet | ||||||
| Total Assets | 8.19B | 6.00B | 5.30B | 4.72B | 5.29B | 3.13B |
| Cash, Cash Equivalents and Short-Term Investments | 838.13M | 795.70M | 805.26M | 720.77M | 1.81B | 351.00M |
| Total Debt | 1.84B | 481.89M | 844.32M | 1.08B | 1.42B | 1.21B |
| Total Liabilities | 3.32B | 1.56B | 1.59B | 1.74B | 2.19B | 2.02B |
| Stockholders Equity | 4.85B | 4.42B | 3.70B | 2.96B | 3.08B | 1.11B |
Cash Flow | ||||||
| Free Cash Flow | -406.37M | 829.29M | 605.49M | -97.41M | 48.23M | -304.00M |
| Operating Cash Flow | 1.58B | 1.37B | 1.12B | 353.06M | 985.13M | 607.66M |
| Investing Cash Flow | -2.08B | -745.34M | -512.41M | -938.85M | -963.01M | -748.19M |
| Financing Cash Flow | 360.03M | -699.02M | -418.10M | -666.82M | 1.41B | 287.54M |
Visco Vision Inc. Peers Comparison
Overall Rating
- TW:678281Outperform
TW:410460.5Neutral
TW:497755Neutral
TW:336240Underperform
TW:314928Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:6782 | 81Outperform | TWD 18.14B | 15.06 | ― | 2.97% | 23.29% | 55.47% |
| TW:4104 | 61Neutral | TWD 13.58B | 14.58 | ― | 5.97% | 11.09% | 7.11% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:4977 | 55Neutral | TWD 17.02B | 55.79 | ― | 1.10% | -25.66% | -39.19% |
| TW:3362 | 40Underperform | TWD 18.28B | -74.38 | ― | 0.80% | -2.57% | -1044.10% |
| TW:3149 | 28Underperform | TWD 17.75B | -32.84 | ― | ― | 7.57% | 16.45% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6782 | Visco Vision Inc. | 282.50 | 109.32 | 63.12% | |
| TW:3149 | G-Tech Optoelectronics Corporation | 68.20 | 33.36 | 95.74% | |
| TW:3362 | Ability Opto-Electronics Technology Co., Ltd. | 128.00 | 28.80 | 29.04% | |
| TW:4104 | Excelsior Medical Co., Ltd. | 72.00 | -5.81 | -7.47% | |
| TW:4977 | PCL Technologies, Inc. | 186.00 | 83.39 | 81.28% | |
| TW:7917 | Centera Photonics Inc | 311.00 | -99.00 | -24.15% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026